0001209191-18-056114.txt : 20181024 0001209191-18-056114.hdr.sgml : 20181024 20181024205522 ACCESSION NUMBER: 0001209191-18-056114 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181015 FILED AS OF DATE: 20181024 DATE AS OF CHANGE: 20181024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arenberg Michael CENTRAL INDEX KEY: 0001755509 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-31615 FILM NUMBER: 181137421 MAIL ADDRESS: STREET 1: 10260 BUBB ROAD CITY: CUPERTINO STATE: CA ZIP: 95014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DURECT CORP CENTRAL INDEX KEY: 0001082038 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943297098 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10260 BUBB RD CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: 4087771417 MAIL ADDRESS: STREET 1: 10260 BUBB ROAD CITY: CUPERTINO STATE: CA ZIP: 95014 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2018-10-15 0 0001082038 DURECT CORP DRRX 0001755509 Arenberg Michael 10260 BUBB ROAD CUPERTINO CA 95014 0 1 0 0 Chief Financial Officer Common Stock 14426 D Incentive Stock Option (right to buy) 3.11 2019-01-27 Common Stock 10938 D Incentive Stock Option (right to buy) 2.80 2019-02-13 Common Stock 7813 D Incentive Stock Option (right to buy) 2.09 2019-05-21 Common Stock 7169 D Incentive Stock Option (right to buy) 2.18 2020-01-22 Common Stock 25000 D Incentive Stock Option (right to buy) 3.26 2021-01-20 Common Stock 45255 D Incentive Stock Option (right to buy) 1.21 2023-02-05 Common Stock 50625 D Incentive Stock Option (right to buy) 2.09 2024-01-31 Common Stock 63017 D Incentive Stock Option (right to buy) 0.88 2025-01-09 Common Stock 76328 D Incentive Stock Option (right to buy) 1.16 2026-01-28 Common Stock 61750 D Incentive Stock Option (right to buy) 1.31 2027-01-09 Common Stock 2464 D Incentive Stock Option (right to buy) 1.31 2027-01-09 Common Stock 69469 D Non-Qualified Stock Option (right to buy) 3.11 2019-01-27 Common Stock 24062 D Non-Qualified Stock Option (right to buy) 2.80 2019-02-13 Common Stock 17187 D Non-Qualified Stock Option (right to buy) 2.09 2019-05-21 Common Stock 35831 D Non-Qualified Stock Option (right to buy) 2.18 2020-01-22 Common Stock 18791 D Non-Qualified Stock Option (right to buy) 2.18 2020-01-22 Common Stock 55000 D Non-Qualified Stock Option (right to buy) 3.26 2021-01-20 Common Stock 74745 D Non-Qualified Stock Option (right to buy) 1.21 2023-02-05 Common Stock 39375 D Non-Qualified Stock Option (right to buy) 1.21 2023-02-05 Common Stock 51260 D Non-Qualified Stock Option (right to buy) 2.09 2024-01-31 Common Stock 26983 D Non-Qualified Stock Option (right to buy) 2.09 2024-01-31 Common Stock 39167 D Non-Qualified Stock Option (right to buy) 0.88 2025-01-09 Common Stock 57808 D Non-Qualified Stock Option (right to buy) 0.88 2025-01-09 Common Stock 18672 D Non-Qualified Stock Option (right to buy) 1.16 2026-01-28 Common Stock 43983 D Non-Qualified Stock Option (right to buy) 1.16 2026-01-28 Common Stock 14250 D Non-Qualified Stock Option (right to buy) 1.31 2027-01-09 Common Stock 52306 D Non-Qualified Stock Option (right to buy) 1.31 2027-01-09 Common Stock 16031 D Non-Qualified Stock Option (right to buy) 1.40 2027-06-19 Common Stock 10000 D Fully vested as of the date of this filing. This ISO option Grant Dated January 9, 2015 will vest as follows: 1/16 of the total shares subject to the option shall vest quarterly over 4 years following the Grant Date. This ISO option Grant Dated January 28, 2016 will vest as follows: 1/16 of the total shares subject to the option shall vest quarterly over 4 years following the Grant Date. This ISO option Grant Dated January 9, 2017 will vest as follows: 1/16 of the total shares subject to the option shall vest quarterly over 4 years following the Grant Date. Following the time the reporting person became an executive officer, but prior to the filing of this Form 3, the reporting person was granted certain stock options that were reported on Form 4 and filed on October 17, 2018. /s/ Michael Arenberg 2018-10-24